Skip to main content
Clinical Trials/NCT03580252
NCT03580252CompletedNot Applicable

Reliability of Hammersmith Examination in Prediction of Neurological Outcomes In Preterm Infants - Observational Study (REHAPENO)

Abha International Private Hospital1 site in 1 country50 target enrollmentStarted: March 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Non inferiority of MRI to Hammersmith assessments in developmental outcomes

Study Overview

Brief Summary

In this study workers are trying to test the correlation between Hammersmith Infant Neurological Examination and MRI brain/cranial ultrasound with early prediction of neurological developmental outcome of preterm neonates. This study is prospective cross-sectional collecting the data of patients according to daily standard medical practice

Detailed Description

The primary aim of this study is to evaluate the neurobehavioural performance of infants born preterm using the Hammersmith Infant Neurological Examination (HINE) in standard medical practice and compare it with the gold standard MRI and ultrasound imagings. It would be possible to check do we need to use all the 3 examinations or Hammersmith examination would be enough reliable predictor. Secondary aim is to explore the relationships between MRI brain /cranial us abnormalities and HINE at term-equivalent age in infants born preterm in prediction of neurological outcome at 1 year of chronological age.

This study will be only single arm/single group. This group would receive the regular practice of MRI, Ultrasound (US) and Hammersmith assessments. The 3 assessments would be compared in relationships with the neonatal developmental outcomes (developmental milestones).

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Preterm infants <37 weeks' GA at birth admitted to the neonatal nurseries at the Abha Private Hospital in Kingdom of Saudi Arabia. This project aims to recruit 50 infants <37weeks at birth over a 1-year stating from march 2018

Exclusion Criteria

  • •-infants with congenital or chromosomal abnormalities

Outcomes

Primary Outcomes

Non inferiority of MRI to Hammersmith assessments in developmental outcomes

Time Frame: 12 month

Hammersmith assessment will be tested for non-inferiority to gold standard assessment method by MRI in terms of sensitivity for early prediction of delayed neurological syndrome (DNS)

Secondary Outcomes

  • Superiority testing for Hammersmith assessment to gold standard MRI(12 month)
  • Comparing the correlations of MRI and US scans with early prediction of DNS(12 month)
  • Comparing the correlations of US scan and Hammersmith assessment(12 month)
  • Hammersmith health economic analyses if primary endpoint is achieved(12 month)
  • Specificity and sensitivity for all techniques MRI, US and Hammersmith(12 month)

Investigators

Sponsor
Abha International Private Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials